Craniospinal magnetic resonance imaging enhanced with Gd-DTPA in von Hippel-Lindau disease.
The case presented illustrates the utility of enhancement with gadolinium diethylenetriaminepenta-acetic acid in magnetic resonance imaging (MRI) of the brain and the spinal cord in a patient with von Hippel-Lindau disease. The patient had numerous lesions in the brain stem and the cervical and the thoracic spinal cord, most of which were not demonstrated or were only poorly demonstrated with noncontrast MRI. Contrast-enhanced MRI should be performed in two sessions with a separate dose of contrast agent for each. Regular follow-up examinations should be conducted in the same manner.
Hardjasudarma
M
M
Department of Radiology, Louisiana State University Medical Center, Shreveport.
Fowler
M
M
D000328:Adult; D001921:Brain / Q000473:pathology*; D003287:Contrast Media; D019786:Gadolinium DTPA; D006801:Humans; D007089:Image Enhancement; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D009942:Organometallic Compounds; D004369:Pentetic Acid; D013116:Spinal Cord / Q000473:pathology*; D006623:von Hippel-Lindau Disease / Q000175:diagnosis*
D003287:Contrast Media; D009942:Organometallic Compounds; D004369:Pentetic Acid; D019786:Gadolinium DTPA